-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...
More »SEARCH RESULT
Total Matching Records found : 171
Central Government Health Schemes now open to all senior citizens in Delhi -Kundan Pandey
-Down to Earth Doctors will now have to prescribe only those medicines and procedures that have been listed under schemes Here is some good news for all the senior citizens in Delhi. From September 1, 2014, they can avail free consultation under 20 Central Government Health Schemes (CGHS). On Friday, the Union Minister of Health and Family Welfare, Harsh Vardhan, unveiled a pilot project that can be extended further in future. "This is...
More »Major diabetes, cardiac drugs to become up to 35% cheaper -Rupali Mukherjee
-The Times of India MUMBAI: In a move that has surprised and shaken the industry, prices of widely-used expensive anti-diabetic and cardiac medicines will reduce by as much as 35% over the next few weeks, with the drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control. In a rare invocation of a lesser-used provision in the Drug Price Control Order (DPCO), NPPA has fixed the prices...
More »Pharma pricing norms set to be tightened -Sushmi Dey
-The Business Standard Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market,...
More »Of primary importance -N Devadasan
-The Indian Express We need better primary health centres more than AIIMS-like institutions. The ministry of health is reportedly planning to open 10 more AIIMS-like institutes as well as cancer centres in different states. Creating new cancer centres is desirable, given the burden of the disease and the inadequate number of treatment centres. Today, cancer is one of the main causes of premature mortality in our country, and the 25 regional cancer...
More »
